Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Revenue

Burning Rock Biotech had revenue of 107.94M CNY in the quarter ending March 31, 2026, a decrease of -18.89%. This brings the company's revenue in the last twelve months to 514.43M, down -1.69% year-over-year. In the year 2025, Burning Rock Biotech had annual revenue of 539.57M with 4.60% growth.

• Revenue (ttm): 514.43M CNY
• Revenue Growth: -1.69%
• P/S Ratio: 1.03
• Revenue / Employee: 771,258 CNY
• Employees: 667
• Market Cap: 76.46M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	539.57M	23.75M	4.60%
Dec 31, 2024	515.82M	-21.61M	-4.02%
Dec 31, 2023	537.44M	-25.80M	-4.58%
Dec 31, 2022	563.24M	55.38M	10.90%
Dec 31, 2021	507.86M	77.96M	18.13%
Dec 31, 2020	429.90M	48.23M	12.64%
Dec 31, 2019	381.68M	172.81M	82.74%
Dec 31, 2018	208.87M	97.70M	87.89%
Dec 31, 2017	111.17M	-	-

Data Source: Fiscal.ai Last updated: Jun 9, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error